Gilead Sciences
GILD
#91
Rank
โ‚น16.870 T
Marketcap
โ‚น13,590
Share price
-0.64%
Change (1 day)
34.61%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): โ‚น566.39

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is โ‚น600.28. In 2024 the company made an earnings per share (EPS) of โ‚น34.99 a decrease over its 2023 EPS that were of โ‚น418.90.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น566.391518.93%
2024โ‚น34.99-91.65%
2023โ‚น418.9023.98%
2022โ‚น337.89-25.86%
2021โ‚น455.734850%
2020โ‚น9.21-97.64%
2019โ‚น390.360.9%
2018โ‚น386.9018.71%
2017โ‚น325.92-64.88%
2016โ‚น928.04-18.45%
2015โ‚น1,13855.28%
2014โ‚น732.85296.02%
2013โ‚น185.0517.89%
2012โ‚น156.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,025 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น125.21-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น220.21-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,119 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,319 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1,012 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น411.54-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1,319 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น672.71 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA